| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/10/2011 | WO2010148335A3 Structured viral peptide compositions and methods of use |
| 02/10/2011 | WO2010127284A3 Dual variable domain immunoglobulins and uses thereof |
| 02/10/2011 | WO2010028798A8 Multivalent antibodies |
| 02/10/2011 | WO2010012045A8 Influenza vaccines |
| 02/10/2011 | WO2010003992A8 Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer |
| 02/10/2011 | WO2009158618A8 Avian reoviridae |
| 02/10/2011 | US20110035817 Siva 3, its preparation and use |
| 02/10/2011 | US20110034543 DNA Vaccination For Treatment of Multiple Sclerosis and Insulin-Dependent Diabetes Mellitus |
| 02/10/2011 | US20110034541 Inhibitors of DNA Immunostimulatory Sequence Activity |
| 02/10/2011 | US20110034449 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 02/10/2011 | US20110034379 Gastrin Compositions And Formulations, And Methods Of Use And Preparation |
| 02/10/2011 | US20110033954 Biofunctionalized quantum dots for biological imaging |
| 02/10/2011 | US20110033551 Nucleic acid microspheres, production and delivery thereof |
| 02/10/2011 | US20110033549 Stabilisation of Proteins |
| 02/10/2011 | US20110033547 Dehydrated chitosan nanoparticles |
| 02/10/2011 | US20110033524 Treatment of tumors |
| 02/10/2011 | US20110033522 Reagents for inducing an immune response |
| 02/10/2011 | US20110033521 Molecules and Methods of Using Same for Treating MCP-1/CCR2 Associated Diseases |
| 02/10/2011 | US20110033502 Live genetically attenuated malaria vaccine |
| 02/10/2011 | US20110033501 Recombinant bacterium capable of eliciting an immune response against enteric pathogens |
| 02/10/2011 | US20110033500 Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb-neisseria meningitidis |
| 02/10/2011 | US20110033499 Anti-viral nutraceutical |
| 02/10/2011 | US20110033498 METHODS OF PREVENTING AND TREATING VIRAL INFECTIONS BY INHIBITING THE DelSGYLATION ACTIVITY OF OTU DOMAIN-CONTAINING VIRAL PROTEINS |
| 02/10/2011 | US20110033497 Vaccine for protection against lawsonia intracellularis, mycoplasma hyopneumoniae and porcine circo virus |
| 02/10/2011 | US20110033496 Vaccine for protection against lawsonia intracellulars |
| 02/10/2011 | US20110033495 Methods and compositions for reducing the impact of enteric diseases |
| 02/10/2011 | US20110033494 Anti-Infective Agents and Uses Thereof |
| 02/10/2011 | US20110033493 Vaccine |
| 02/10/2011 | US20110033492 Vaccines for brucellosis |
| 02/10/2011 | US20110033491 Multicomponent meningococcal vaccine |
| 02/10/2011 | US20110033490 Compositions and methods for diagnosing and/or treating influenza infection |
| 02/10/2011 | US20110033489 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 02/10/2011 | US20110033488 Agents and methods for treatment of anxiety disorders |
| 02/10/2011 | US20110033487 Vaccines and diagnostics for the ehrlichioses |
| 02/10/2011 | US20110033486 Gene expression markers for crohn's disease |
| 02/10/2011 | US20110033485 Analogues of glycolipids useful as immunoadjuvants |
| 02/10/2011 | US20110033484 LprG AS A CHAPERONE OF IMMUNE ADJUVANTS |
| 02/10/2011 | US20110033483 Single-chain multivalent binding proteins with effector function |
| 02/10/2011 | US20110033482 Her3 as a determinant for the prognosis of melanoma |
| 02/10/2011 | US20110033481 Prospective identification and characterization of breast cancer stem cells |
| 02/10/2011 | US20110033480 Methods and compositions involving nucleotide repeat disorders |
| 02/10/2011 | US20110033479 Proteins ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis vulgaris and poststreptococcal diseases |
| 02/10/2011 | US20110033478 Canine thymic stromal lymphopoietin protein and uses thereof |
| 02/10/2011 | US20110033477 Method for diagnosing and treating chronic psychiatric illnesses and markers and targets for such methods |
| 02/10/2011 | US20110033476 Compositions and methods for the therapy and diagnosis of influenza |
| 02/10/2011 | US20110033475 Use of beta-glucans against biological warfare weapons and pathogens including anthrax |
| 02/10/2011 | US20110033474 Inhibition of platelet aggregation |
| 02/10/2011 | US20110033473 Anti influenza antibodies and uses thereof |
| 02/10/2011 | US20110033472 Tumor Endothelial Marker 5-alpha Molecules and Uses Thereof |
| 02/10/2011 | US20110033471 Methods and compositions for modulating tumor cell activity |
| 02/10/2011 | US20110033470 Human G-Protein Coupled Receptor |
| 02/10/2011 | US20110033469 Leukotriene b4 binding soluble lipocalin receptor from ixodes ricinus |
| 02/10/2011 | US20110033468 Ophthalmic Drug Delivery System Containing Phospholipid and Cholesterol |
| 02/10/2011 | US20110033467 Compositions and methods comprising a ligand of chemerinr |
| 02/10/2011 | US20110033466 Human transcriptomes |
| 02/10/2011 | US20110033465 Anti-pcsk9 and methods for treating lipid and cholesterol disorders |
| 02/10/2011 | US20110033464 Immunoglobulin fusion protein formulations |
| 02/10/2011 | US20110033463 Apheresis, administration of agent, or combination thereof |
| 02/10/2011 | US20110033462 Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus (jev) and their use |
| 02/10/2011 | US20110033461 Combination Therapy for the Treatment of Cancer |
| 02/10/2011 | US20110033460 ANTI-ErbB2 ANTIBODIES |
| 02/10/2011 | US20110033459 Combination therapy with a compound acting as a platelet adp receptor inhibitor |
| 02/10/2011 | US20110033458 Combinations comprising epothilones and pharmaceutical uses thereof |
| 02/10/2011 | US20110033457 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 02/10/2011 | US20110033456 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 02/10/2011 | US20110033455 Methods For Inhibiting The Binding Of Endosialin To Ligands |
| 02/10/2011 | US20110033454 Methods For Treating Diseases Using Antibodies to Aminophospolipids |
| 02/10/2011 | US20110033453 Use of pyrimidine derivatives for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members |
| 02/10/2011 | US20110033452 Anti-Glypican 3 Antibody Having Modified Sugar Chain |
| 02/10/2011 | US20110033451 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor |
| 02/10/2011 | US20110033450 Antibody Against Anthrax Toxins |
| 02/10/2011 | US20110033449 Human immune therapies using a CD27 agonist alone or in combination with other immune modulators |
| 02/10/2011 | US20110033448 Inhibitors of LL-37 Mediated Immune Reactivity to Self Nucleic Acids |
| 02/10/2011 | US20110033447 Methods for Treating Osteoarthritis Pain By Administering a Nerve Growth Factor Antagonist and Compositions Containing the Same |
| 02/10/2011 | US20110033446 Treatment of HIV-1-infected individuals to reduce risk of coronary artery disease and suppress virus replication |
| 02/10/2011 | US20110033445 Carbohydrate-containing pan cancer marker |
| 02/10/2011 | US20110033444 Genetic variants in a hypertension susceptibility gene Stk39 and uses thereof |
| 02/10/2011 | US20110033443 Method for Increasing Bone Mass |
| 02/10/2011 | US20110033442 Targets, including yap1, for antifungal drug discovery and therapy |
| 02/10/2011 | US20110033441 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 02/10/2011 | US20110033419 Methods and Compositions for Treating Cancer |
| 02/10/2011 | US20110033418 Treatment of diseases caused by viral infection |
| 02/10/2011 | US20110033417 2,3-substituted indole derivatives for treating viral infections |
| 02/10/2011 | US20110033416 RNA Vaccines |
| 02/10/2011 | US20110033389 Modified antibodies for passive immunotherapy |
| 02/10/2011 | US20110033378 Cysteine Engineered Antibodies For Site-Specific Conjugation |
| 02/10/2011 | US20110033376 Treatment of Melanoma |
| 02/10/2011 | CA2806840A1 Method for in vivo expansion of t regulatory cells |
| 02/10/2011 | CA2770304A1 Anti-rsv immunogens and methods of immunization |
| 02/10/2011 | CA2770075A1 Composition for treating hbv infection |
| 02/10/2011 | CA2769882A1 Targeting of bone marrow neovasculature |
| 02/10/2011 | CA2769748A1 Immunogenic composition comprising variants of staphylococcal clumping factor a |
| 02/10/2011 | CA2769610A1 Immunogenic composition comprising antigenic s. aureus proteins |
| 02/10/2011 | CA2769464A1 Humanized anti-amyloid-.beta. oligomer antibody |
| 02/10/2011 | CA2769231A1 Porphyromonas gingivalis polypeptides |
| 02/10/2011 | CA2769221A1 Concentrated polypeptide formulations with reduced viscosity |
| 02/10/2011 | CA2769001A1 Novel proteins |
| 02/09/2011 | EP2281891A2 Streptococcus antigens |
| 02/09/2011 | EP2281885A1 Combination therapy for the treatment of ocular neovascular disorders |
| 02/09/2011 | EP2281882A1 Nucleic acid containing chimeric gene derived from hepatitis type-c virus |